SEC Form 4 · accession 0001209191-16-117180
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin C Johnson
Director
Period of report
Apr 20, 2016
Accepted (ET)
May 3, 2016 · 8:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 20, 2016 | A | 2,150 | $7.15 | A | 119,904 | D | |
| Common Stock | holding | — | — | — | 117,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.78 | holding | — | — | — | May 6, 2016 | May 6, 2020 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Mr. Johnson received 2,150 restricted shares on April 20, 2016 for his service on the board of directors. These shares will vest ratably over each of the next four quarters at 537.5 shares per quarter.
- F2On May 6, 2015, Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.